Tizanidine Hydrochloride
Product Images NDC 75834-209

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 75834-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tizanidine 01)

Chemical structure of tizanidine hydrochloride as shown in the image, featuring a chlorinated thiazole ring and an attached aminopyridine moiety.*

FDA Label Image

Figure 1 (Tizanidine 02)

A pharmacokinetic curve showing plasma Tizanidine concentration (ng/mL) versus hours from dosing. The graph compares different Tizanidine formulations and dosages (2 mg and 4 mg tablets and capsules) taken with and without food, illustrating concentration changes over approximately 24 hours post-dose.*

FDA Label Image

Figure 2 (Tizanidine 03)

A line graph comparing improvement in Ashworth Score over 6 time points among three groups: 18 mg tizanidine, 6 mg tizanidine, and placebo. The vertical axis represents improvement, while the horizontal axis indicates time. Each group shows different improvement trends, with 18 mg tizanidine showing the highest improvement.*

FDA Label Image

Figure 3 (Tizanidine 04)

A line graph depicting improvement in Ashworth scores over study weeks for Tizanidine (mean dose 28.8 mg) and placebo groups. The vertical axis represents improvement scores, while the horizontal axis marks time points: end of titration (week 3), end of maintenance (week 7), and study endpoint. Data include error bars indicating variability.*

FDA Label Image

Principal Display Panel (2 mg Capsule Bottle Label)

Tizanidine Hydrochloride Capsules 2 mg, 150 capsules per container, labeled by Nivagen Pharmaceuticals, Inc. The label includes dosage strength, NDC 75834-207-15, storage instructions, and warnings. Manufactured by Cadila Pharmaceuticals Ltd, Gujarat, India, with contact details of the labeler in Sacramento, CA. The label advises not to interchange with similarly named products and states Rx only.*

FDA Label Image

Principal Display Panel (4 mg Capsule Bottle Label)

Label for Tizanidine Hydrochloride Capsules 4 mg by Nivagen Pharmaceuticals, Inc. The package contains 150 capsules. The label includes storage instructions, dosage reference, manufacturer details (Cadila Pharmaceuticals Ltd., India), barcode, and a warning that the capsules are not interchangeable with tizanidine tablets or Zanaflex tablets. Marked Rx only.*

FDA Label Image

Principal Display Panel (6 mg Capsule Bottle Label)

Label for Tizanidine Hydrochloride Capsules 6 mg by Nivagen Pharmaceuticals, Inc. The label shows a quantity of 150 capsules, states Rx only, and includes storage instructions and a barcode. It also highlights that capsules are not interchangeable with tizanidine tablets or Zanflex tablets and provides manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.